Centiva Capital’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-53,912
Closed -$617K 1175
2025
Q2
$617K Buy
53,912
+36,731
+214% +$414K 0.01% 860
2025
Q1
$232K Buy
+17,181
New +$285K 0.01% 1221
2024
Q2
Sell
-12,245
Closed -$321K 2098
2024
Q1
$322K Buy
12,245
+4,971
+68% +$142K 0.01% 1209
2023
Q4
$229K Buy
+7,274
New +$197K 0.01% 1347
2021
Q1
Sell
-14,812
Closed -$367K 1167
2020
Q4
$367K Buy
+14,812
New +$352K 0.01% 585
2020
Q1
Sell
-10,990
Closed -$199K 649
2019
Q4
$199K Sell
10,990
-5,018
-31% -$83.3K 0.01% 681
2019
Q3
$239K Buy
+16,008
New +$260K 0.01% 475

Other funds holding CC

Centiva Capital's CC Position: Q3 2025 in Review

Centiva Capital sold out of Chemours (CC) in Q3 2025, closing a stake of 53,912 shares — an estimated $617K sold.

Centiva Capital first reported a position in CC in Q3 2019 and held it in 7 quarters. The position peaked at $617K in Q2 2025. 428 funds tracked by Wall St. Rank hold CC as of Q3 2025.

  • Centiva Capital reported no remaining Chemours position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 53,912 Chemours shares in Q3 2025, an estimated $617K.
  • Centiva Capital first reported a position in Chemours in Q3 2019 and held it in 7 quarters.
  • Centiva Capital's Chemours position peaked at $617K in Q2 2025.
  • 428 funds tracked by Wall St. Rank held Chemours as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.